Alzheimer’s Pipeline Drugs
Market Dynamics, Trends,
Opportunities, Drivers,
Challenges and
Influence Factors
Global Alzheimer’s Pipeline Introduction and overview
Growing prevalence rates of Alzheimer’s disease globally and
rising geriatric population worldwide is anticipated to fuel the
growth of Alzheimer’s drugs market. With the globally
increasing ageing population, the number of patients suffering
from Alzheimer’s disease is projected to grow during the
forecast period. According to the World Health Organization
(WHO) between the years 2015 and 2050, the proportion of the
world’s population over 60 years will nearly double from 12% to
22%. It is estimated that dementia affects 46.8 million people
worldwide with an estimated cost of USD 818 billion.
Alzheimer’s disease is the most common cause of dementia,
with 9.9 million people newly diagnosed with dementia each
year. Unfortunately there is no cure for Alzheimer’s, which has
become one of the greatest public health challenges globally.
These factors are expected fuel the Alzheimer’s Drugs Market in
the forecast period. Current treatments focus on delaying the